In the Journals

ILD affects systemic sclerosis outcomes

December 4, 2019
The presence of interstitial lung disease at systemic sclerosis diagnosis appears to affect disease outcomes, with data indicating that even mild…
In the JournalsPerspective

Apremilast reduces number of Behçet's-related oral ulcers

December 4, 2019
Treatment with apremilast resulted in a greater reduction in the number of oral ulcers related to Behçet’s syndrome, compared with placebo, but…
In the Journals

Risk for immune-mediated inflammatory diseases 5-times higher in psoriasis

December 3, 2019
Among a large cohort of patients with psoriasis, researchers found around 20% had an immune-mediated inflammatory disease develop before psoriasis…
Feature

Some experts, lawmakers concerned about Hahn’s agenda as FDA commissioner

December 3, 2019
In an 18 to 5 vote earlier today, the Senate Health, Education, Labor and Pensions Committee sent the nomination of Stephen M. Hahn
In the JournalsPerspective

Symptoms, imaging abnormalities differ in patients with TAK, GCA

December 3, 2019
Among patients with Takayasu’s and giant cell arteritis, certain symptoms, such as carotidynia, are more closely associated with vascular…
In the JournalsPerspective

EULAR: Immunosuppressant use only to spare steroids in Sjögren’s syndrome

December 2, 2019
Rheumatologists treating patients with systemic Sjögren’s syndrome should tailor their therapies to organ-specific severity, with…
Meeting News

One-year delay in diagnosis common for Down syndrome arthropathy

November 29, 2019
ATLANTA — Patients with Down syndrome arthropathy experience a year-long delay from symptom onset to diagnosis, according to a presentation at…
In the Journals

Hair loss in systemic lupus may indicate active disease

November 27, 2019
Hair loss in systemic lupus erythematosus can indicate active disease, and nonscarring alopecia shows changes unique to lupus on histology and direct…
Meeting News

Scarcity of lupus assays in developing countries limit utility of international criteria, trials

November 27, 2019
ATLANTA — Limited access to supportive laboratory assays in developing countries significantly reduces the diagnostic utility of the ACR/EULAR…
Meeting News

RA remission with abatacept, methotrexate best maintained by continued treatment

November 27, 2019
ATLANTA — Among patients with early rheumatoid arthritis who are positive for anti-citrullinated protein antibodies, and achieve remission with…
Meeting News

Lorecivivint yields improved patient-reported outcome scores in knee OA

November 27, 2019
ATLANTA — A 0.07 mg intra-articular injection of lorecivivint, a Wnt pathway inhibitor, was associated with improvements in patient-reported…

European Commission approves subcutaneous infliximab biosimilar for RA

November 26, 2019
The European Commission has approved the subcutaneous formulation of Celltrion’s infliximab biosimilar for adult patients with active…
Meeting News

TULIP-1: Anifrolumab fails primary endpoint, confers clinical benefit in SLE

November 26, 2019
ATLANTA — Although a 300 mg dose of anifrolumab failed to meet the primary endpoint of systemic lupus erythematosus responder index, a post-hoc…
FDA News

FDA warns 15 companies for selling products containing CBD

November 26, 2019
The FDA recently issued warning letters to 15 companies for illegally selling products containing cannabidiol, or CBD, according to a press release.
In the Journals

US life expectancy drops after decades of improvement

November 26, 2019
Life expectancy among adults in the United States increased for nearly 6 decades but eventually slowed over time and then dropped for 3 straight…
Meeting News

Novel therapies provide options for patients with spondyloarthritides

November 26, 2019
ATLANTA — Certolizumab pegol and bimekizumab were associated with improvements ranging from work productivity to disease activity in patients…
Meeting News

ADA2 levels elevated in systemic JIA with macrophage activation syndrome

November 26, 2019
ATLANTA — Systemic juvenile idiopathic arthritis with macrophage activation syndrome was marked by elevated adenosine deaminase 2 levels…
Meeting NewsPerspective

Absence of pediatric studies blocking critical biologic DMARDs for JIA

November 25, 2019
ATLANTA — Lax FDA policies on required pediatric studies for approved biologic DMARDs have exacerbated an already critical lack of approved…
Meeting News

Exposure to TNF inhibitors increases psoriasis risk in children with IBD, JIA

November 25, 2019
Children with inflammatory bowel disease, juvenile idiopathic arthritis and chronic noninfectious osteomyelitis had an increased rate of psoriasis…
Meeting News

Gout linked to increased cardiovascular disease risk

November 25, 2019
ATLANTA — Gout is associated with an increased risk for cardiovascular disease, as calculated via population-level cardiovascular risk…